Chapter
Concerns over release of Pfizer vaccine data
59:53 - 1:13:13 (13:20)
The author discusses his concerns about the lack of release of Pfizer vaccine data, which has not been opened up since the early clinical trial data and was not reviewed in an advisory committee meeting before the FDA granted full authorization.
Clips
Pfizer has petitioned the judge to join the lawsuit in support of the FDA's request to release the vaccine study data, but the company seems to be uncomfortable bringing this part of the game to light due to potential lawsuits and legal complications.
59:53 - 1:02:50 (02:56)
Summary
Pfizer has petitioned the judge to join the lawsuit in support of the FDA's request to release the vaccine study data, but the company seems to be uncomfortable bringing this part of the game to light due to potential lawsuits and legal complications.
ChapterConcerns over release of Pfizer vaccine data
Episode#263 – John Abramson: Big Pharma
PodcastLex Fridman Podcast
Pfizer has joined the fight against a judge who believes they should release the data behind their COVID-19 vaccine.
1:02:50 - 1:07:12 (04:22)
Summary
Pfizer has joined the fight against a judge who believes they should release the data behind their COVID-19 vaccine. The FDA and Pfizer argue that releasing the documents would be too costly, but some believe they simply do not want to reveal embarrassing information.
ChapterConcerns over release of Pfizer vaccine data
Episode#263 – John Abramson: Big Pharma
PodcastLex Fridman Podcast
The release of COVID-19 vaccine data from the FDA and Pfizer is causing concern due to their reluctance to share the full early clinical trial data with the public, and not holding an advisory committee meeting before granting full authorization.
1:07:12 - 1:11:17 (04:05)
Summary
The release of COVID-19 vaccine data from the FDA and Pfizer is causing concern due to their reluctance to share the full early clinical trial data with the public, and not holding an advisory committee meeting before granting full authorization. The divide over vaccination is now branching into different groups, including pro-vaccine, triple mask, Democrat, liberal, and anti-mandate individuals.
ChapterConcerns over release of Pfizer vaccine data
Episode#263 – John Abramson: Big Pharma
PodcastLex Fridman Podcast
The Pfizer-BioNTech vaccine may go down as one of the most profitable drugs ever with an expected $65 billion in sales over the first two years of the pandemic, revealing issues with the profit-driven pharmaceutical industry model in the U.S.
1:11:17 - 1:13:13 (01:55)
Summary
The Pfizer-BioNTech vaccine may go down as one of the most profitable drugs ever with an expected $65 billion in sales over the first two years of the pandemic, revealing issues with the profit-driven pharmaceutical industry model in the U.S.